420 related articles for article (PubMed ID: 18570787)
1. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
[TBL] [Abstract][Full Text] [Related]
2. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
3. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B
Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
Ruiz CE; Kipshidze N; Chiam PT; Gogorishvili I
Catheter Cardiovasc Interv; 2008 Jun; 71(7):921-6. PubMed ID: 18412251
[TBL] [Abstract][Full Text] [Related]
6. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
7. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
8. Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies.
Wöhrle J; Kochs M; Spiess J; Nusser T; Hombach V; Merkle N
Circulation; 2009 Jun; 119(23):3002-8. PubMed ID: 19487592
[TBL] [Abstract][Full Text] [Related]
9. Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience.
Węglarz P; Konarska Kuszewska E; Spisak Borowska K; Machowski J; Drzewiecka-Gerber A; Kuszewski P; Jackson CL; Opala G; Trusz Gluza M
Kardiol Pol; 2012; 70(5):478-84. PubMed ID: 22623240
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of cryptogenic stroke or TIA in patients with patent foramen ovale successfully treated by using different kind of percutaneous occluder devices: five-year follow-up.
de Cillis E; Acquaviva T; Basile DP; Cipriani F; Bortone AS
Minerva Cardioangiol; 2010 Aug; 58(4):425-31. PubMed ID: 20938409
[TBL] [Abstract][Full Text] [Related]
11. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
12. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N
Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525
[TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
Han Y; Zhang X; Zhang F
J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
[TBL] [Abstract][Full Text] [Related]
17. Occlusion of PFO with a dedicated adjustable device: influence on one year outcome.
Kleber FX; Winkelmann A; Stretz A; Sonntag SM; Bruch L; Rademacher G; Sparenberg P; Schmehl I
EuroIntervention; 2010 Aug; 6(3):367-70. PubMed ID: 20884416
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation following device closure of patent foramen ovale.
Burow A; Schwerzmann M; Wallmann D; Tanner H; Sakata T; Windecker S; Meier B; Delacrétaz E
Cardiology; 2008; 111(1):47-50. PubMed ID: 18239392
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
